Your browser doesn't support javascript.
loading
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.
Martínez-Trufero, Javier; Cruz Jurado, Josefina; Hernández-León, C Nieves; Correa, Raquel; Asencio, Jose Manuel; Bernabeu, Daniel; Alvarez, Rosa; Hindi, Nadia; Mata, Cristina; Marquina, Gloria; Martínez, Virginia; Redondo, Andres; Floría, Luis Javier; Gómez-Mateo, M Carmen; Lavernia, Javier; Sebio, Ana; Garcia Del Muro, Xavier; Martin-Broto, Javier; Valverde-Morales, Claudia.
Afiliación
  • Martínez-Trufero J; Hospital Universitario Miguel Servet, Medical Oncology Department, Zaragoza, Spain. Electronic address: jmtrufero@seom.org.
  • Cruz Jurado J; Hospital Universitario Canarias, Medical Oncology Department, Santa Cruz de Tenerife, Spain.
  • Hernández-León CN; Hospital Universitario Canarias, Pathology Department, Santa Cruz de Tenerife, Spain.
  • Correa R; Hospital Virgen de la Victoria, Radiation Oncology Department, Málaga, Spain.
  • Asencio JM; Hospital Universitario Gregorio Marañón, Surgery Department, Madrid, Spain.
  • Bernabeu D; Hospital Universitario La Paz, Radiology Department, Madrid, Spain.
  • Alvarez R; Hospital Universitario Gregorio Marañón, Medical Oncology Department, Madrid, Spain.
  • Hindi N; University Hospital "Fundacion Jimenez Diaz" Madrid, Medical Oncology Department, Madrid, Research Institute FJD-UAM, TBsarc, CITIUS III, Seville, Spain.
  • Mata C; Hospital Universitario Gregorio Marañón, Pediatric and Adolescent Hemato-Oncology Department, Madrid, Spain.
  • Marquina G; Hospital Universitario Clínico San Carlos, Medical Oncology Department, Madrid, Spain.
  • Martínez V; Hospital Universitario La Paz, Medical Oncology Department, Madrid, Spain.
  • Redondo A; Hospital Universitario La Paz, Medical Oncology Department, Madrid, Spain.
  • Floría LJ; Hospital Universitario Miguel Servet, Orthopedic and Traumatology Department, Zaragoza, Spain.
  • Gómez-Mateo MC; Hospital Universitario Miguel Servet, Pathology Department, Zaragoza, Spain.
  • Lavernia J; Instituto Valenciano de Oncología, Medical Oncology Department, Valencia, Spain.
  • Sebio A; Hospital Universitario Santa Creu i Sant Pau, Medical Oncology Department, Barcelona, Spain.
  • Garcia Del Muro X; Instituto Catalan Oncología Hospitalet, Medical Oncology Department, Barcelona, Spain.
  • Martin-Broto J; University Hospital "Fundacion Jimenez Diaz" Madrid, Medical Oncology Department, Madrid, Research Institute FJD-UAM, TBsarc, CITIUS III, Seville, Spain.
  • Valverde-Morales C; Hospital Vall D'Hebron, Medical Oncology Department, Barcelona, Spain.
Cancer Treat Rev ; 99: 102260, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34340159
ABSTRACT
Among all Soft Tissue sarcomas there are some subtypes with low incidence and/or peculiar clinical behaviour, that need to be consider separately. Most of them are orphan diseases, whose biological characteristics imply a clearly different diagnostic and therapeutic approach from other more common sarcoma tumors. We present a brief and updated multidiciplinary review, focused on practical issues, aimed at helping clinicians in decision making. In this second part we review these subtypes Alveolar Soft Part Sarcoma, Epithelioid Sarcoma, Clear Cell Sarcoma, Desmoplastic Small Round Cell Tumor, Rhabdoid Tumor, Phyllodes Tumor, Tenosynovial Giant Cell Tumors, Myoepithelial Tumor, Perivascular Epithelioid Cell Neoplasms (PEComas), Extraskeletal Myxoid Chondrosarcoma, NTRK-fusions Sarcomas. Most of them present their own radiological and histopathological feautures, that are essential to know in order to achieve early diagnosis. In some of them, molecular diagnosis is mandatory, not only in the diagnosis, but also to plan the treatment. On the other hand, and despite the low incidence, a great scientific research effort has been made to achieve new treatment opportunities for these patients even with approved indications. These include new treatments with targeted therapies and immunotherapy, which today represent possible therapeutic options. It is especially important to be attentive to new and potential avenues of research, and to promote the conduct of specific clinical trials for rare sarcomas.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Guideline / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Guideline / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2021 Tipo del documento: Article